Vertex Pharmaceuticals Incorporated
VX1.DE News Today: Stay Updated with the Latest Vertex Pharmaceuticals Incorporated News in Real Time
Find VX1.DE news now at Meyka AI. Stay informed with the latest Vertex Pharmaceuticals Incorporated stocks updates, including price news, market analysis, and expert insights.
FHS.AX Surges 100% on High Volume Trading, May 11 2026
FHS.AX stock doubled to A$0.002 on May 11 with 704,094 shares traded. Freehill Mining explores iron ore, copper, and gold in Australia and Chile.
JBR.CN Stock Doubles on May 11 with 100% Gain in Single Day
JBR.CN stock surges 100% to C$0.03 on May 11, 2026. James Bay Resources gains momentum in oil & gas sector.
KHTRF: RBC Capital Maintains Outperform Rating, May 2026
RBC Capital maintains Outperform rating on Knight Therapeutics (KHTRF), raising price target to C$9.50 from C$8.50.
BSET Insider Selling: John Bassett III Disposes 280 Shares May 11, 2026
BSET insider John Bassett III sold 280 shares at $16.52 on Nov 12, 2026. Officer disposition signals executive activity.
LECN.SW Gains 8.9% on SIX as Energy Storage Demand Rises
LECN.SW stock jumps 8.9% to CHF0.098 on SIX. Leclanché S.A. energy storage solutions gain traction amid renewable energy growth.
GSK Agreement Strengthens China Ties After $500M Hengrui Collaboration
Global pharmaceutical firm GSK has made another significant move to strengthen and expand its footprint in China. The company recently entered a $500 million collaboration with Chinese drugmaker Jiangsu Hengrui Pharmaceuticals. This deal is not just about money. It is about strategy, science, and global expansion. The agreement allows both companies to co-develop up to…
AMRX Directors Buy 69,638 Shares in Amneal Pharmaceuticals May 2026
Two AMRX directors acquired 34,819 shares each on May 7, 2026. Nark and Kiely’s insider buying signals confidence in Amneal Pharmaceuticals.
LVL.CN Stock Surges 200% on CNQ: Level 14 Ventures May 11
LVL.CN stock jumps 200% to C$0.60 on CNQ exchange. Level 14 Ventures mining exploration update.
ESCA Insider Buying: 3 Directors Acquire 6,450 Shares May 8
Three ESCA directors acquired 2,150 shares each on May 8, 2026. Insider buying signals confidence in Escalade stock performance.